Formulations:
- Parenteral > General injections > IV: 10 mg in vial (vinblastine sulfate)
Parenteral > General injections > IV: 10 mg in vial (vinblastine sulfate); 10 mg per 10 mL in vial (vinblastine sulfate)
Indications:
- Unspecified malignant neoplasms of ill-defined or unspecified sites
- Other specified gliomas of brain
- Hodgkin lymphoma
- Other specified malignant neoplasms of the ovary
- Germ cell tumour of testis
- Kaposi sarcoma of unspecified primary site
- Anaplastic large cell lymphoma, ALK-negative
- Anaplastic large cell lymphoma, ALK-positive
- Langerhans cell histiocytosis
Source: EML workbook import
Product metadata will be available once the catalog entry is complete.
Formulations:
- Parenteral > General injections > IV: 10 mg in vial (vinblastine sulfate)
Parenteral > General injections > IV: 10 mg in vial (vinblastine sulfate); 10 mg per 10 mL in vial (vinblastine sulfate)
Indications:
- Unspecified malignant neoplasms of ill-defined or unspecified sites
- Other specified gliomas of brain
- Hodgkin lymphoma
- Other specified malignant neoplasms of the ovary
- Germ cell tumour of testis
- Kaposi sarcoma of unspecified primary site
- Anaplastic large cell lymphoma, ALK-negative
- Anaplastic large cell lymphoma, ALK-positive
- Langerhans cell histiocytosis
Source: EML workbook import